Artificial intelligence unifies knowledge and actions in drug repositioning

Research output: Contribution to journalReview articlepeer-review


Drug repositioning aims to reuse existing drugs, shelved drugs, or drug candidates that failed clinical trials for other medical indications. Its attraction is sprung from the reduction in risk associated with safety testing of new medications and the time to get a known drug into the clinics. Artificial Intelligence (AI) has been recently pursued to speed up drug repositioning and discovery. The essence of AI in drug repositioning is to unify the knowledge and actions, i.e. incorporating real-world and experimental data to map out the best way forward to identify effective therapeutics against a disease. In this review, we share positive expectations for the evolution of AI and drug repositioning and summarize the role of AI in several methods of drug repositioning.

Original languageEnglish (US)
Pages (from-to)803-813
Number of pages11
JournalEmerging Topics in Life Sciences
Issue number6
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Artificial intelligence unifies knowledge and actions in drug repositioning'. Together they form a unique fingerprint.

Cite this